Belviq is a drug used to help obese people lose weight and keep it off. Belviq is the first new anti-obesity drug to be approved by the FDA in over a decade. Belviq is manufactured by Eisai, a Japanese pharmaceutical company. The drug has been available in Europe since 2006. The FDA originally rejected Belviq in 2010, citing concerns about its long-term safety. However, the FDA reversed its decision and approved Belviq in 2012.

How does Belviq work?

Belviq works by activating a brain receptor known as the 5-HT2C receptor. This receptor is involved in regulating appetite and satiety (feeling full). Belviq is thought to work by increasing the activity of the 5-HT2C receptor, which leads to reduced appetite and increased satiety.

What are the side effects of Belviq?

The most common Belviq Side Effects include:

  • Headache
  • Dizziness
  • Fatigue
  • Nausea
  • Dry mouth

Belviq is a serotonin 2C receptor agonist that is used as an adjunct to diet and exercise to treat obesity. Belviq has been linked to an increased risk of cancer. The FDA has recommended that Belviq be removed from the market due to the risk of cancer. The FDA based their recommendation on a clinical trial that showed an increased risk of cancer in patients taking Belviq.

The class action lawsuit is currently in the early stages. No settlement has been reached and no trial date has been set.

If you or a loved one has taken Belviq and been diagnosed with cancer, you may be eligible to join the class action lawsuit.

Belviq Class Action Lawsuit

The Belviq Class Action Lawsuit is about whether Arena Pharmaceuticals and Eisai Inc. failed to warn consumers about the risk of cancer associated with Belviq.

On February 11, 2016, a class action lawsuit was filed against Eisai, the manufacturer of Belviq. The lawsuit alleges that Eisai knew or should have known that Belviq increased the risk of cancer, but failed to warn consumers of this risk. The lawsuit is seeking compensation for patients who have been diagnosed with cancer after taking Belviq.

The lawsuit is currently in the early stages. No settlement has been reached and no trial date has been set.

How Can I Join the Belviq Class Action Lawsuit?

If you or a loved one has taken Belviq and been diagnosed with cancer, you may be eligible to join the class action lawsuit. To join the lawsuit, you will need to contact a personal injury lawyer. A personal injury lawyer can review your case and determine if you are eligible to join the Belviq lawsuit. If you are eligible, the lawyer will file a lawsuit on your behalf.

If you are not eligible to join the lawsuit, you may still be able to file a Belviq cancer lawsuit.

Can I Sue If I Have Not Been Diagnosed With Cancer?

You may still be able to sue or make Belviq recall if you have not been diagnosed with cancer, but the amount of compensation you may be eligible to receive will be lower. To learn more about your legal rights, you should contact a personal injury lawyer.